Zobrazeno 1 - 10
of 102
pro vyhledávání: '"EMA, European Medicines Agency"'
Autor:
Paula Pleguezuelos-Beltrán, Patricia Gálvez-Martín, Daniel Nieto-García, Juan Antonio Marchal, Elena López-Ruiz
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
instname
This research was funded by Fundacion Mutua Madrilena (FMM-AP17196-2019) , the Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia (ERDF funds, projects B-CTS-230-UGR18, PY18-2470, A-CTS-180-UGR20, SOMM17-6109, PYC20
Autor:
Kerstin Breithaupt-Grögler, Tim Hardman, Jan de Hoon, Yves Donazzolo, Sylvie Rottey, Hildegard Sourgens, Steffan Stringer
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
The European Federation for Exploratory Medicines Development (EUFEMED) organized a meeting in Leuven, Belgium entitled ‘The new FIH EMA guideline: Disruptive or constructive?’ to provide a forum for stakeholders to discuss the guideline’s oper
Externí odkaz:
https://doaj.org/article/b23e4873d6a34cf49989b280af3ddd46
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Objective: To assess shares of reimbursed orphan drugs and agreement in reimbursement decision-making in different European Union member states as well as to define odds for reimbursement influenced by the presence of conditional approval or exceptio
Externí odkaz:
https://doaj.org/article/fe5d4fecc29b4ae8a378341a5139b056
Autor:
Sallam Hasan Abdallah, Hady Shahin, Ahmed T. El-Serafi, Cathrine Lagerwall, Ingrid Steinvall, Moustafa Elmasry, Folke Sjöberg
Publikováno v:
Regenerative Therapy
Regenerative Therapy, Vol 18, Iss, Pp 401-407 (2021)
Regenerative Therapy, Vol 18, Iss, Pp 401-407 (2021)
Introduction Regenerative solutions of the skin represent a hope for burn victims with extensive skin loss and chronic wound patients. The development of xeno-free workflow is crucial for clinical application in compliance with the directives of the
Autor:
Fanny Caputo, C.A.W. David, R.J. Vandebriel, Matteo Santin, B. Halamoda-Kenzaoui, A. Howarth, Sven Even F. Borgos, S. Bremer-Hoffmann, Marco Siccardi, Neill J. Liptrott
Publikováno v:
Journal of Controlled Release
JOURNAL OF CONTROLLED RELEASE
JOURNAL OF CONTROLLED RELEASE
Nanotechnology-based health products are providing innovative solutions in health technologies and the pharmaceutical field, responding to unmet clinical needs. However, suitable standardised methods need to be available for quality and safety assess
Publikováno v:
Journal of Controlled Release
Liposomal formulations for the treatment of cancer and other diseases are the most common form of nanotechnology enabled pharmaceuticals (NEPs) submitted for market approval and in clinical application today. The accurate characterization of their ph
Autor:
Pierre Van Damme, S. Valckx, Maren Vranckx, Niel Hens, Koen Pepermans, Thomas Neyens, Frederik Verelst, Greet Hendrickx, Jonas Crevecoeur, Philippe Beutels
Publikováno v:
Vaccine
Background: A year after the start of the COVID-19 outbreak, the global rollout of vaccines gives us hope of ending the pandemic. Lack of vaccine confidence, however, poses a threat to vaccination campaigns. This study aims at identifying individuals
Autor:
Hulya Gokmen-Ozel, Esther van Dam, Amaya Belanger-Quintana, Fran Rohr, Alexandra Jung, Júlio César Rocha, Laurie Bernstein, Anita MacDonald, Heather Bausell, Margret Heddrich-Ellerbrok
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 28, Iss, Pp 100771-(2021)
Molecular genetics and metabolism reports, 28:100771. ELSEVIER SCIENCE BV
Molecular Genetics and Metabolism Reports
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Molecular genetics and metabolism reports, 28:100771. ELSEVIER SCIENCE BV
Molecular Genetics and Metabolism Reports
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Funding Information: Outside the submitted work, the authors disclose the following. Bausell H received personal fees from BioMarin, Ultragenyx, Horizon and Vitaflo. Bélanger-Quintana A reports personal fees from BioMarin, Nutricia, Vitaflo, Orphan
Publikováno v:
Vaccine
Objective To compare prevalence of skin, nose and gingival bleedings after receipt of adeno-vectored or mRNA-vaccines against covid-19. The hypothesis is that milder symptoms indicating altered thrombocyte function may affect a larger proportion of v
Publikováno v:
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X, Vol 3, Iss, Pp 100095-(2021)
International Journal of Pharmaceutics: X, Vol 3, Iss, Pp 100095-(2021)
Digitalization of any manufacture industry is a key step in any progress of the production process. The process of digitalization includes both increased use of robotics, automatization solutions and computerization, thereby allowing to reduce costs,